Goldman Sachs’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-16,009
Closed -$42K 7564
2015
Q3
$42K Sell
16,009
-4,639
-22% -$11.6K ﹤0.01% 6854
2015
Q2
$54K Buy
20,648
+3,041
+17% +$18.9K ﹤0.01% 6848
2015
Q1
$129K Buy
17,607
+6,589
+60% +$47.7K ﹤0.01% 6312
2014
Q4
$84K Sell
11,018
-1,669
-13% -$11.6K ﹤0.01% 6643
2014
Q3
$88K Buy
+12,687
New +$130K ﹤0.01% 6637

Other funds holding GBIM

Goldman Sachs's GBIM Position: Q4 2015 in Review

Goldman Sachs sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q4 2015, closing a stake of 16,009 shares — an estimated $42K sold.

Goldman Sachs first reported a position in GBIM in Q3 2014 and held it in 5 quarters. The position peaked at $129K in Q1 2015. 12 funds tracked by Wall St. Rank hold GBIM as of Q4 2015.

  • Goldman Sachs reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Goldman Sachs sold 16,009 GLOBEIMMUNE INC COM STK (DE) shares in Q4 2015, an estimated $42K.
  • Goldman Sachs first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q3 2014 and held it in 5 quarters.
  • Goldman Sachs's GLOBEIMMUNE INC COM STK (DE) position peaked at $129K in Q1 2015.
  • 12 funds tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q4 2015.

Based on Goldman Sachs's 13F filing for Q4 2015, filed 16 Feb 2016.